PDT Partners, LLC - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$220,946
-30.4%
65,954
-0.0%
0.03%
-41.2%
Q4 2022$317,388
-18.8%
65,985
-4.0%
0.05%
-13.6%
Q3 2022$391,000
-75.9%
68,754
-69.4%
0.06%
-57.9%
Q1 2022$1,622,000
-34.9%
224,660
-19.3%
0.14%
-26.3%
Q4 2021$2,490,000278,4870.19%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 1,260,000$4,712,40033.11%
BML Capital Management, LLC 2,236,239$8,363,5347.52%
TANG CAPITAL MANAGEMENT LLC 3,026,455$11,318,9421.67%
Stonepine Capital Management, LLC 752,088$2,812,8091.02%
Bain Capital Life Sciences Investors, LLC 2,485,638$9,296,2860.96%
CM Management, LLC 250,000$9350.91%
EcoR1 Capital, LLC 6,995,861$26,164,5200.64%
Cormorant Asset Management, LP 1,547,181$5,786,4570.32%
SECTORAL ASSET MANAGEMENT INC 501,537$1,875,7480.31%
Auour Investments LLC 177,000$661,9800.28%
View complete list of ATEA PHARMACEUTICALS INC shareholders